MedPath

Influence of adding growth hormone in frozen embryo transfer cycle outcome

Phase 3
Conditions
infertility.
Female infertility
Registration Number
IRCT20091018002604N5
Lead Sponsor
Vice chancellor for research,Shahid Sadoughi University of Medical Science,Yazd,Iran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

20-40 years old infertile patient candidate for frozen thawed embryo transfer

Exclusion Criteria

uterus malformation-sever endometriosis and adenomyosis-uterus adhesion-recurrent implantation failure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: 2weeks after embryo transfer. Method of measurement: serum BHCG.
Secondary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 2weeks after positive BHCG. Method of measurement: vaginal sonography.
© Copyright 2025. All Rights Reserved by MedPath